The heterogeneity in response to catheter ablation amongst atrial fibrillation (AF) patients classified according to arrhythmia duration highlights the need for improved phenotyping. Multimodal assessment may better characterise the spectrum of pathophysiology present amongst patients classified as having paroxys...
Neil Bodagh, V. Vigneswaran, A. Gharaviri et al.· European Heart Journal Open· 0 citations
Conventional clinical trials remain the benchmark for evaluating therapeutic safety and efficacy, yet they are constrained by escalating costs, withdrawal over the extended follow‐up periods, recruitment difficulties, ethical limits, and a restricted ability to characterize heterogeneous populations. In silico clinical...
Maximilian Balmus, Sheng-Ya Wang, Edward W. G. Ashton et al.· Clinical pharmacology and th...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.